1. Long‐term entecavir or tenofovir disoproxil fumarate therapy in treatment‐naïve chronic hepatitis B patients in the real‐world setting. Issue 5 (28th November 2014) Authors: Idilman, R.; Gunsar, F.; Koruk, M.; Keskin, O.; Meral, C. E.; Gulsen, M.; Elhan, A. H.; Akarca, U. S.; Yurdaydin, C. Journal: Journal of viral hepatitis Issue: Volume 22:Issue 5(2015) Page Start: 504 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Tumour necrosis factor‐alpha, interleukin‐10, interferon‐gamma and vitamin D receptor gene polymorphisms in patients with chronic hepatitis delta. Issue 4 (22nd July 2013) Authors: Karatayli, S. C.; Ulger, Z. E.; Ergul, A. A.; Keskin, O.; Karatayli, E.; Albayrak, R.; Ozkan, M.; Idilman, R.; Yalcin, K.; Bozkaya, H.; Uzunalimoğlu, O.; Yurdaydin, C.; Bozdayi, A. M. Journal: Journal of viral hepatitis Issue: Volume 21:Issue 4(2014) Page Start: 297 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Viral dominance patterns in chronic hepatitis delta determine early response to interferon alpha therapy. Issue 11 (10th July 2018) Authors: Lutterkort, G. L.; Wranke, A.; Hengst, J.; Yurdaydin, C.; Stift, J.; Bremer, B.; Hardtke, S.; Keskin, O.; Idilman, R.; Manns, M. P.; Dienes, H. P.; Falk, C.; Wedemeyer, H.; Heidrich, B. Journal: Journal of viral hepatitis Issue: Volume 25:Issue 11(2018) Page Start: 1384 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗